This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
Virtual Event, Worldwide : 5 - 6 December 2023
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Kristian Helin and Ho Man Chan
TARGETING EPIGENETICS IN CANCER: SESSION 1
Chair: Mark Dawson
Ricky Johnstone Peter MacCallum Cancer Centre, Victoria, Australia
'Targeting epigenetic regulators of transcription in cancer'
Q&A 13:30 - 13:55
Celine Vallot Institut Curie, Paris, France
'Epigenetic targeting of chemoresistance in cancer'
Q&A 14:15 - 14:30
Refreshment Break
Chair: Ho Man Chan
Eytan Stein MSKCC, New York, USA
'Novel epigenetic therapies for acute myeloid leukemia'
Q&A 15:05 - 15:20
Proffered Paper 1
Q&A 15:30 - 15:40
Proffered Paper 2
Q&A 15:50 - 16:00
Refreshment break
Chair: Jingwen Zhang
Melissa Pappalardi GSK, Philadelphia, USA
'Development of new inhibitors of DNA methylation'
Q&A 16:35 - 16:50
POSTER SPOTLIGHTS
END OF DAY 1 WEBINAR
VIRTUAL POSTER DISCUSSION SESSION 1
Listed times are in Central European Time (CET)
VIRTUAL POSTER DISCUSSION SESSION 2
WELCOME TO DAY TWO
Kristian Helin and Ho Man Chan
TARGETING EPIGENETICS IN CANCER: SESSION 2
Chair: Mark Dawson
Oliver Raush Storm Therapeutics Ltd, Cambridge, UK
'Inhibition of RNA modifying enzymes for the treatment of cancer'
Q&A 14:25 - 14:40
Proffered Paper 3
Q&A 14:50 - 15:00
Refreshment Break
Chair: Jingwen Zhang
Proffered Paper 4
Q&A 15:25 - 15:35
Cigall Kadoch Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
'Role of SWI / SNF mutations in cancer'
Q&A 15:55 - 16:10
Refreshment Break
Chair: Cigall Kadoch
Ernesto Guccione EG Lab, Mount Sinai, New York, USA
'Precision medicine in solid tumors'
Q&A 16:45 - 16:55
Sangeeta Goswami MD Anderson Cancer Center, Houston, USA
‘Combined use of epigenetic and immunotherapies in cancer’.
Q&A 17:15 - 17:30
DISCUSSION SESSION
'How to use Epigenetic Therapies in Cancer' and 'What epigenomic features need to be routinely measured in clinical protocol? Has this been done already? If not, why not?'
This will be an open forum with SPC members and speakers, Kristian, Ho Man, Eytan, Sangeeta and Celine
SUMMARY AND CLOSE
Kristian Helin and Ho Man Chan
Abstract submission deadline:
09 October 2023
Registration deadline:
13 November 2023
Histone and DNA. Image credit: Eric de Vries for Dawson lab
Dietary requirements (in-person events only)
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Data
Your details will be retained in our electronic registration database and used for correspondence from the EACR in line with our Privacy Policy.
Sharing your details with others
Please click below if you agree we can share your name, email and postal address with participants and exhibitors, who may use them to contact you.
Don't Share
Share
Please note: you have selected NOT to share your details with participants and exhibitors.
You can click above to change this.
Invoicing information
We will use the email address in your EACR account to communicate with you. However, during the checkout process you will need to enter the name and contact details of the person paying for your registration, if this is different to your own details. Please make sure you have this information to hand.
Terms and Conditions
Please read our Membership and Events Terms and Conditions before completing your registration.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you do not wish to take part please inform the photographer.
Confirm Registration